Research suggests that certain compounds derived from goji berry, specifically lycium barbarum glycopeptide, have shown protective effects in preclinical studies, though the available evidence directly related to blood sugar regulation is limited in this particular set of findings. The single identified study investigated retinal protection against ischemia-reperfusion injury in mice and cell cultures, finding benefits related to inflammation, cellular aging, and cell survival rather than directly examining blood sugar outcomes. This study was conducted in animal and laboratory models, which means its findings cannot be directly applied to human blood sugar regulation without further clinical investigation. Overall, the current evidence base here is too narrow and indirect to draw meaningful conclusions about goji berry's role in blood sugar regulation, and more targeted human trials would be needed to assess that specific application.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Lycium barbarum glycopeptide mitigates retinal ischemia-reperfusion injury th... | Other | 2025 | Neutral | 72 |